Georgia Pollens Clinical Research Centers, Inc., in association with Allergy & Asthma Clinics of Georgia, PC, is conducting a clinical trial for the treatment of asthma. The trial is a Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ENV-294 in Adult Participants with Moderate-to-Severe Asthma, using a novel ORAL asthma.
Participants must be non-smokers, between 18 to 75 years of age, and have a cell phone on which they are willing to upload the research app to complete the daily diary. You may view the complete list of Inclusions and Exclusions below.
If you are interested, please review the contact Jonnie Owens at 229-438-7100 (ext. 170) or by email at This email address is being protected from spambots. You need JavaScript enabled to view it. for further information.